Research Grade Tulisokibart

Catalog No.

DHB54001

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Human

Isotype

IgG1-kappa

Clonality

Monoclonal

Target

TNFSF15, Vascular endothelial cell growth inhibitor, VEGI, TL1, TNF ligand-related molecule 1, Tumor necrosis factor ligand superfamily member 15

Concentration

4 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

O95150

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

CAS: 2648504-55-4

Clone ID

Tulisokibart

Comparative Efficacy of Different Targeted Therapies in Patients With Moderate-to-Severe Ulcerative Colitis: Systematic Review/Network Meta-Analysis and Mechanistic Overview., PMID:40468857

Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial., PMID:40456235

Tulisokibart shows promise for Crohn's disease., PMID:40456234

[Intestinal fibrosis in Crohn's disease : towards new therapeutic options?]., PMID:40079288

TL1A, a novel alarmin in airway, intestinal, and autoimmune disorders., PMID:40010414

TL1A: A model for a precision medicine approach in the treatment of Crohn's disease and ulcerative colitis., PMID:39521604

Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis., PMID:39321363

Document Download

Research Grade Tulisokibart.pdf